One-year Prospective Observational Study of BMI Change Effect of 5-alpha Reductase Inhibitor in Korean BPH Patients.

Trial Profile

One-year Prospective Observational Study of BMI Change Effect of 5-alpha Reductase Inhibitor in Korean BPH Patients.

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Jul 2011

At a glance

  • Drugs Alpha adrenergic receptor antagonists; Dutasteride
  • Indications Benign prostatic hyperplasia
  • Focus Pharmacodynamics
  • Most Recent Events

    • 20 Jul 2011 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
    • 20 Jul 2011 Actual initiation date (May 2006) added as reported by ClinicalTrials.gov.
    • 20 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top